NO20075764L - Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen - Google Patents

Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen

Info

Publication number
NO20075764L
NO20075764L NO20075764A NO20075764A NO20075764L NO 20075764 L NO20075764 L NO 20075764L NO 20075764 A NO20075764 A NO 20075764A NO 20075764 A NO20075764 A NO 20075764A NO 20075764 L NO20075764 L NO 20075764L
Authority
NO
Norway
Prior art keywords
combined use
gastrointestinal disorders
proton pump
pump inhibitor
prostaglandin compound
Prior art date
Application number
NO20075764A
Other languages
English (en)
Norwegian (no)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20075764L publication Critical patent/NO20075764L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20075764A 2005-04-12 2007-11-09 Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen NO20075764L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67023805P 2005-04-12 2005-04-12
PCT/JP2006/308001 WO2006109881A1 (en) 2005-04-12 2006-04-11 Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
NO20075764L true NO20075764L (no) 2008-01-14

Family

ID=36685683

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075764A NO20075764L (no) 2005-04-12 2007-11-09 Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen

Country Status (18)

Country Link
US (1) US8962688B2 (cg-RX-API-DMAC7.html)
EP (1) EP1871380B1 (cg-RX-API-DMAC7.html)
JP (2) JP5711442B2 (cg-RX-API-DMAC7.html)
KR (2) KR20140069182A (cg-RX-API-DMAC7.html)
CN (1) CN101198334B (cg-RX-API-DMAC7.html)
AU (1) AU2006234632B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0610557A2 (cg-RX-API-DMAC7.html)
CA (1) CA2602812C (cg-RX-API-DMAC7.html)
DK (1) DK1871380T3 (cg-RX-API-DMAC7.html)
ES (1) ES2371658T3 (cg-RX-API-DMAC7.html)
IL (1) IL186374A (cg-RX-API-DMAC7.html)
NO (1) NO20075764L (cg-RX-API-DMAC7.html)
NZ (1) NZ562763A (cg-RX-API-DMAC7.html)
PL (1) PL1871380T3 (cg-RX-API-DMAC7.html)
PT (1) PT1871380E (cg-RX-API-DMAC7.html)
RU (1) RU2468800C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006109881A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200709072B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1562604E (pt) * 2002-10-23 2012-04-09 Sucampo Ag Compostos de prostaglandina para o tratamento de obesidade
JP5427029B2 (ja) * 2006-09-06 2014-02-26 スキャンポ・アーゲー 消化管の重炭酸分泌を促進するための方法および組成物
US20090012165A1 (en) * 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
WO2009157397A1 (ja) * 2008-06-23 2009-12-30 日本新薬株式会社 非ステロイド性抗炎症剤投与に伴う腸管傷害治療剤
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
CN103781482A (zh) * 2011-04-19 2014-05-07 苏坎波公司 用于调节细胞因子活性的方法
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
KR20160015100A (ko) 2014-07-30 2016-02-12 미래파인켐 주식회사 프로스타글란딘 중간체의 제조방법
KR20170025682A (ko) 2015-08-31 2017-03-08 미래파인켐 주식회사 프로스타글란딘 유도체의 신규한 제조방법
CN107582556A (zh) * 2017-09-15 2018-01-16 成都泠汐尚品科技有限公司 一种治疗消化性溃疡的药物复方制剂
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
JPH0688966B2 (ja) * 1987-01-28 1994-11-09 株式会社アールテック・ウエノ プロスタグランジンｅ類およびそれを含む抗潰瘍剤
US5380709A (en) * 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5225439A (en) * 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5221763A (en) * 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
TW249226B (cg-RX-API-DMAC7.html) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
WO1997047595A1 (en) * 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Endothelin antagonist
SE9804314D0 (sv) * 1998-12-14 1998-12-14 Astra Ab New pharmaceutical formulation
JP4332316B2 (ja) * 1999-10-15 2009-09-16 スキャンポ・アーゲー 二環式化合物組成物およびその安定化方法
AU4472701A (en) * 2000-04-06 2001-10-23 Sucampo Ag Bile secretion promoting composition
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
BR0212233A (pt) * 2001-08-31 2004-10-05 Sucampo Ag Abridor de canal de cloreto
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
KR101164838B1 (ko) * 2002-12-27 2012-07-11 수캄포 아게 복부 불쾌감 치료용 프로스타글랜딘의 유도체
JP2006516562A (ja) * 2003-01-24 2006-07-06 ステート オブ イスラエル、ミニストリー オブ アグリカルチャー 抗酸化活性を増強するための相乗的な組成物及び方法
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物

Also Published As

Publication number Publication date
JP2013121972A (ja) 2013-06-20
NZ562763A (en) 2010-12-24
CA2602812A1 (en) 2006-10-19
KR20070119753A (ko) 2007-12-20
KR20140069182A (ko) 2014-06-09
IL186374A (en) 2013-05-30
PT1871380E (pt) 2011-11-21
CA2602812C (en) 2014-11-18
WO2006109881A1 (en) 2006-10-19
EP1871380A1 (en) 2008-01-02
BRPI0610557A2 (pt) 2010-06-29
EP1871380B1 (en) 2011-10-19
US8962688B2 (en) 2015-02-24
RU2007141655A (ru) 2009-05-20
AU2006234632B2 (en) 2011-10-27
KR101466980B1 (ko) 2014-12-01
DK1871380T3 (da) 2011-11-21
ES2371658T3 (es) 2012-01-05
RU2468800C2 (ru) 2012-12-10
US20070276006A1 (en) 2007-11-29
CN101198334B (zh) 2013-02-06
PL1871380T3 (pl) 2012-03-30
JP5711442B2 (ja) 2015-04-30
IL186374A0 (en) 2008-03-20
JP2008535774A (ja) 2008-09-04
ZA200709072B (en) 2008-11-26
AU2006234632A1 (en) 2006-10-19
CN101198334A (zh) 2008-06-11

Similar Documents

Publication Publication Date Title
NO20075764L (no) Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen
EA201170521A1 (ru) Новые соединения
EA200870292A1 (ru) Соединения на основе имидазола, композиции, содержащие их, и способы их применения
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
NO20073790L (no) Kjemiske forbindelser
NO20073788L (no) Kjemiske forbindelser
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
TR201818983T4 (tr) İnflamatuvar Cilt Bozukluklarının Tedavisine Yönelik Olarak Sübstitüe Edilmiş Tetrasiklin Bileşikleri
NO20092637L (no) Fremgangsmater for behandling
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
TW200605886A (en) Indazoles useful in treating cardiovascular diseases
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
UA94749C2 (en) Benzimidazole modulators of vr1
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
NO20071378L (no) Tiazolo-naftylsyrer.
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20080993L (no) Fremgangsmate for a forbedre arvakenhet
ATE437642T1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
DE60329326D1 (de) Tace inhibitoren
NO20065297L (no) Anvendelse av GPCR54 ligander til behandling av infertilitet
NO20080839L (no) Isotopsubstituerte protonpumpeinhibitorer
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application